230 related articles for article (PubMed ID: 11716158)
21. Highlights from the First Thalassaemia Forum on Growth and Endocrine Complications in Thalassemia Doha, (October 2-3, 2011).
De Sanctis V; Elawwa A; Angastiniotis M; Eleftheriou A; Kattamis C; Karimi M; El Kholy M; Elsedfy H; Yassin MA; Fiscina B; Soliman AT
Pediatr Endocrinol Rev; 2012 Mar; 9(3):672-9. PubMed ID: 22523836
[No Abstract] [Full Text] [Related]
22. Endocrine abnormalities in patients with Fanconi anemia.
Giri N; Batista DL; Alter BP; Stratakis CA
J Clin Endocrinol Metab; 2007 Jul; 92(7):2624-31. PubMed ID: 17426088
[TBL] [Abstract][Full Text] [Related]
23. Endocrine outcome in long-term survivors of childhood brain tumors.
Shalitin S; Gal M; Goshen Y; Cohen I; Yaniv I; Phillip M
Horm Res Paediatr; 2011; 76(2):113-22. PubMed ID: 21691048
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the patients with thalassemia major for long-term endocrinological complications after bone marrow transplantation.
Aldemir-Kocabaş B; Tezcan-Karasu G; Bircan I; Bircan O; Aktaş-Samur A; Yeşilipek MA
Pediatr Hematol Oncol; 2014 Oct; 31(7):616-23. PubMed ID: 24852067
[TBL] [Abstract][Full Text] [Related]
25. [Endocrine changes in thalassemia major].
Sinisi AA; Criscuolo T; Bellastella A; Perrone L; Barone M; Castaldo G; Faggiano M
Minerva Pediatr; 1986 May; 38(10):375-83. PubMed ID: 3736515
[No Abstract] [Full Text] [Related]
26. Thalamic and hypothalamic tumors of childhood: endocrine late effects.
Oberfield SE; Garvin JH
Pediatr Neurosurg; 2000 May; 32(5):264-71. PubMed ID: 10965274
[TBL] [Abstract][Full Text] [Related]
27. [Endocrine disorders in diabetes mellitus].
Okazaki R; Shibata M; Hayashi T; Tanaka H
Nihon Rinsho; 2002 Aug; 60 Suppl 8():192-7. PubMed ID: 12355746
[No Abstract] [Full Text] [Related]
28. The clinical management of homozygous beta-thalassemia.
Cividalli G
Haematologica; 1979 Feb; 64(1):1-12. PubMed ID: 109360
[No Abstract] [Full Text] [Related]
29. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country.
Gulati R; Bhatia V; Agarwal SS
J Pediatr Endocrinol Metab; 2000 Jun; 13(6):651-6. PubMed ID: 10905390
[TBL] [Abstract][Full Text] [Related]
30. Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects.
Skordis N; Toumba M
Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():300-6. PubMed ID: 21705982
[TBL] [Abstract][Full Text] [Related]
31. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[TBL] [Abstract][Full Text] [Related]
32. Endocrine disorders in Fanconi anemia: recommendations for screening and treatment.
Petryk A; Kanakatti Shankar R; Giri N; Hollenberg AN; Rutter MM; Nathan B; Lodish M; Alter BP; Stratakis CA; Rose SR
J Clin Endocrinol Metab; 2015 Mar; 100(3):803-11. PubMed ID: 25575015
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Bone Disease in Children With Transfusion-Dependent Thalassemia.
Handattu K; Aroor S; Kini P; Ramesh Bhat Y; Shivakumar G; Shastry P; Shetty S
Indian Pediatr; 2022 Dec; 59(12):920-923. PubMed ID: 36036187
[TBL] [Abstract][Full Text] [Related]
34. Is endocrinological assessment and follow-up of children after bone marrow transplantation necessary? How, and for how long?
Cohen A
Pediatr Transplant; 1999 Feb; 3(1):1-4. PubMed ID: 10359024
[No Abstract] [Full Text] [Related]
35. [Long-term endocrine complications after brain tumor treatment--own experience].
Wójcik M; Dolezal-Ołtarzewska K; Kumorowicz-Czoch M; Kalicka-Kasperczyk A; Januś D; Zygmunt-Górska A; Wojtyś J; Korab-Chrzanowska E; Kwiatkowski S; Starzyk J
Przegl Lek; 2010; 67(11):1132-5. PubMed ID: 21442963
[TBL] [Abstract][Full Text] [Related]
36. Endocrine complications in transfusion dependent thalassaemia in Penang Hospital.
Ong CK; Lim SL; Tan WC; Ong EE; Goh AS
Med J Malaysia; 2008 Jun; 63(2):109-12. PubMed ID: 18942294
[TBL] [Abstract][Full Text] [Related]
37. Towards an optimization of the management of endocrine complications of thalassemia.
El Kholy M; Elsedfy H; Soliman A; Anastasi S; Raiola G; De Sanctis V
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):801-5. PubMed ID: 24859503
[TBL] [Abstract][Full Text] [Related]
38. Selected highlights of the VIII International Symposium of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine (ICET-A) on Growth, Puberty and Endocrine Complications in Thalassaemia. Auditorium of the Sultan Qaboos University (SQU) Muscat (Sultanate of Oman), 20th of December 2014.
De Sanctis V; Soliman AT; Wali Y; Elsedfy H; Daar S; Al-Yaarubi SA; Mevada ST; Elshinawy M; Fawzy H; Al-Subhi T; Al-Rawas A; Al-Muslehi M; El Kholy M
Pediatr Endocrinol Rev; 2015 Mar; 12(3):313-22. PubMed ID: 25962210
[TBL] [Abstract][Full Text] [Related]
39. Endocrine complications in patients with beta-thalassemia major.
Aydinok Y; Darcan S; Polat A; Kavakli K; Nigli G; Coker M; Kantar M; Cetingul N
J Trop Pediatr; 2002 Feb; 48(1):50-4. PubMed ID: 11866338
[TBL] [Abstract][Full Text] [Related]
40. [The endocrine complications in thalassemia major].
Anastasi S; Caruso V; Magnano C; Leocata A
Pediatr Med Chir; 1991; 13(1):63-5. PubMed ID: 2052458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
